期刊文献+

阿托伐他汀联合阿魏酸钠治疗糖尿病肾病的疗效及对肾间质纤维化指标的影响分析 被引量:3

Analysis of Curative Effect of Atorvastatin and Sodium Ferulate in Treatment of Diabetic Nephropathy and Effect on the Renal Interstitial Fibrosis Indicators
下载PDF
导出
摘要 目的研究阿托伐他汀联合阿魏酸钠治疗糖尿病肾病的疗效及对肾间质纤维化指标的影响。方法选取2015年1月—2016年1月该院收治的26例糖尿病肾病患者作为研究对象,随机将患者分成两组,一组采用常规的降糖治疗,为常规组,另一组则使用阿托伐他汀联合阿魏酸钠进行治疗,为实验组,对比分析两组患者的治疗效果和肾间质纤维化指标的改变。结果实验组各项观察指标均优于常规组(P<0.05),实验组疗效更好,肾间质纤维化改善更为明显。结论阿托伐他汀联合阿魏酸钠治疗糖尿病肾病疗效确切、明显,治疗效果好,且对各项肾间质纤维化指标具有显著的改善作用,可延缓糖尿病肾病的恶化,该用药方式可在糖尿病肾病的临床治疗中推广应用。 Objective To research the curative effect of atorvastatin and sodium ferulate in treatment of diabetic nephropathy and effect on the renal interstitial fibrosis indicators.Methods26cases of patients with diabetic nephropathy admitted and treated in our hospital from January2015to January2016were selected as the research objects and randomly divided into two groups,the routine group used the routine hypoglycemic therapy,while the experimental group used the atorvastatin and sodium ferulate for treatmetn,and the treatment effect and changes of renal interstitial fibrosis indicators were compared and analyzed.Results Various observation indicators in the experimental group were better than those in the routine group(P<0.05),and the curative effect in the experimental group was better,and the renal interstitial fibrosis improvement was more obvious.Conclusion The curative effect of atorvastatin and sodium ferulate in treatment of diabetic nephropathy is definite and obvious,with good treatment effect,which has an obvious improvement effect on various renal interstitial fibrosis indicators,and prolongs the deterioration of diabetic nephropathy,which can be promoted and applied in clinical treatment.
作者 李莎莎 LI Sha-sha(Department of Nephrology, Shuangyashan Mining Hospital, Shuangyashan, Heilongjiang Province, 155100 China)
出处 《糖尿病新世界》 2017年第22期5-6,共2页 Diabetes New World Magazine
关键词 阿托伐他汀 阿魏酸钠 糖尿病肾病 肾间质纤维化 疗效 Atorvastatin Sodium ferulate Diabetic nephropathy Renal interstitial fibrosis Curative effect
  • 相关文献

二级参考文献33

  • 1黄斌.糖尿病肾病的透析治疗[J].现代临床医学,2009,35(2):153-154. 被引量:4
  • 2李惠清,于海英.阿托伐他汀联合阿魏酸钠治疗糖尿病肾病肾间质纤维化的临床研究[J].中国生化药物杂志,2014,34(4):120-122. 被引量:16
  • 3王瑞英,姚敏,王绵,苏胜偶.2型糖尿病模型大鼠肾小管上皮细胞中TGF-β1的表达及与肾功能的关系[J].中国老年学杂志,2005,25(5):549-551. 被引量:14
  • 4张彩香,李红,刘章锁.辛伐他汀抑制肾间质纤维化的实验研究[J].山西医药杂志,2006,35(4):286-288. 被引量:3
  • 5TACHIBANA H, OGAWA D, SOGAWA N, et al. Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-in- dueed diabeticmice[J]. Am J Physiol Renal Physiol, 2014, 306(1): FI05-F115.
  • 6MISE K, HOSHINO J, UBARA Y, et al. Renal prognosis a longtime after renal biopsy on patients with diabetic nephropathy[J]. Nephrol Dial Transplant, 2014, 29(1): 109-118.
  • 7SHIMIZU M, FURUICHI K, TOYAMA T, et al. Long-term out- comes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy[J]. Diabetes Care, 2013, 36(11): 3655-3662.
  • 8SAGAR SK, ZHANG C, GUO Q, et al. Role of expression of endothelin-I and angiatensin-II and hypoxia-inducible factor-I ct in the kidney tissues of patients with diabetic nephropathy [J]. Saudi J Kidney Dis Transpl, 2013, 24(5): 959-964.
  • 9PRASAD N, GUPTA P, JAIN M, et al. Outcomes of de novo allograft diabetic nephropathy in renal allograft recipients [J]. Exp Clin Transplant, 2013, 11(3): 215-221.
  • 10RUTYER MK, PRAIS HR, CHARLTON-MENYS V, et al. Pro- tection Against Nephropathy in Diabetes with Atorvastatin (PAN- DA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin[J]. Diabet Med, 2011, 28(1): 100-108.

共引文献56

同被引文献21

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部